Acetyl Salicylic Acid in Elderly Patients

german translation / full article

Nina Enthaler


Can secondary prevention by acetyl salicylic acid (ASA) treatment of coronary artery disease (CAD) and cerebral ischemia reduce cardiovascular risk?


A subgroup analysis of a large (but possibly flawed) randomised controlled study showed a signficant risk reduction in patients over 75 years treated by ASA as secondary prevention of cerebral ischemia. A specific analysis for CAD, however, was not done. There is insufficient evidence to draw final conclusions about efficacy of ASA in secondary prevention in elderly patients.

(State: 11.01.2013)

Latest Issue 2/2021

In Focus

  • How Much Economy is Tolerated by „Good“ Medicine?
  • Adult Attention-Deficit Hyperactivity Disorder (ADHD)
  • Medical Education in France